Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
Collen LV, Mitsialis V, Kim DY, Bresnahan M, Yang J, Tuthill M, Combs A, Barends J, Field M, Liu E, Bearup R, Okoroafor I, Klein C, Muise AM, Bousvaros A, Ouahed J, Snapper SB.
Collen LV, et al.
Inflamm Bowel Dis. 2023 Oct 17:izad196. doi: 10.1093/ibd/izad196. Online ahead of print.
Inflamm Bowel Dis. 2023.
PMID: 37847820